Attention Lab Directors: Four CLIA Updates from the Past Year to Examine
CMS tweaked its CE, documentation, and on-site visit requirements for directors
CMS tweaked its CE, documentation, and on-site visit requirements for directors
Clinical labs gain flexibility in meeting regulatory standards while potentially reducing their costs
Learn how CLIA could be used as a blueprint to regulate emerging technologies in an effective and dynamic way
Washington State’s Department of Health details how its medical testing site program meets federal standards
As of March 1, 2026, CMS will move CLIA away from paper-based transactions to improve efficiency and payments
The board was eliminated as part of a sweeping reordering of the Department of Health and Human Services
CAP and AMP officials weigh in on plans to push for a legislative- or CLIA-based approach to future LDT oversight
Marginal LDT scenarios could be where the FDA focuses on next, a lawyer notes
Put into place late last year, the new rules place more emphasis on formal and continuing education requirements
Changes ‘have had a significant impact on the recruitment process for laboratory directors and technical supervisors,’ recruiter says
A PT update went into effect on January 1, focusing on revised acceptance limits, among other modifications